A new dawn in the biology of human reproduction

Nurturing Bright Beginnings for Future Generations

At dawn-bio,

we’re changing the game of reproductive medicine.

Based on our stem-cell based platform technology, we decode the biological signals that embryos need to thrive in nature and bring them to the IVF lab.  We give clinics the power to create more and healthier embryos, turning dreams of families into reality. Because the future of IVF isn’t about choosing from what’s possible – it’s about redefining what’s possible. 

Section 3 Effect

The Problem

every year, millions turn to IVF – and millions fail.

For over 40 years, IVF has been about retrieving eggs and sperm, bringing them together in the lab, observing embryos as they grow and choosing the one with the highest chances of success to place back into the womb.  But success rates remain low. More than two out of three embryo transfers fail, and many patients are lucky if they get one or two good quality blastocysts.

What if the real problem isn’t about finding the right embryo? What if the real problem is that we are not enabling more embryos to thrive in the first place?

Section 4 Image effect

The SOLUTION

dawn-bio is based on a groundbreaking platform technology:

A human stem-cell based embryo and implantation model.  Combining this with deep tech insights and tools allows us to perform unprecedented research and product development for the earliest phases of human embryo development and implantation. 

In a first step, dawn-bio will enable IVF clinics to create more and better embryos – a paradigm shift from ‘selecting’ to first principles based fundamental improvements, thereby giving patients higher chances of success. 

founders effect top

Founders

Dr. Peter Greiner

Dr. Peter Greiner

Co-Founder & CEO

Dr. Alok Javali

Dr. Alok Javali

Co-Founder & Chief Science Officer

Dr. Nicolas Rivron 

Dr. Nicolas Rivron

Co-founder

Thomas Hoffmann

Thomas Hoffmann

Co-founder

Partners & Investors

Contact Us

Reach out to explore collaboration, investment, or clinical partnership opportunities. Let’s shape the future of reproductive medicine—together.